Menu Courses
Masthead CME/CE

Course Overview

Risk Assessment and Prevention of Venous Thromboembolism: Challenges and Practical Strategies for the Federal Healthcare Professional



Co-sponsored by the Duke University School of Medicine and Med-IQ.

Time to complete: 60 Minutes

Released: 4/23/10

Expires: 4/22/11

    Maximum Credits:
  • 1.0 AMA PRA Category 1 Credit(s)
  • 1.0 Accreditation Council for Pharmacy Education (ACPE)

Overview: In January 2010, the Duke University School of Medicine and Med-IQ convened a roundtable of medical experts in venous thromboembolism (VTE) to discuss the recognition and prevention of this condition within the federal healthcare system. These experts reviewed and compared the challenges of deep vein thrombosis and pulmonary embolism risk assessment and thromboprophylaxis in the Department of Veteran Affairs (VA) and active-duty military branches with challenges encountered in general clinical practice. This discussion is particularly timely, given the recent focus on VTE as a prominent public health problem by a number of government bodies and national organizations, including the VA, the United States Surgeon General, and the National Quality Forum. This article focuses on the prevention of VTE in the federal healthcare system and includes key excerpts from the roundtable discussion.


Thomas L. Ortel, MD, PhD
Director, Anticoagulation Management Service
Director, Duke Clinical Coagulation and Platelet Immunology Laboratories
Professor of Medicine and Pathology
Division of Hematology
Duke University Health System
Durham, NC

Philip C. Comp, MD, PhD
Staff Physician and Associate Chief of Staff for Research
Oklahoma City VA Medical Center
Oklahoma City, OK

Stuart T. Haines, PharmD, FCCP, BCPS
Professor and Pharmacotherapy Specialist
University of Maryland School of Pharmacy
Baltimore, MD
Clinical Pharmacy Specialist, Primary Care
West Palm Beach VA Medical Center
West Palm Beach, FL

Col. (Ret.) John B. Holcomb, MD, FACS
Vice Chair and Professor of Surgery
Director, Center for Translational Injury Research
University of Texas
Health Science Center at Houston
Houston, TX

This activity has been approved for AMA PRA Category 1 Credit™.

This activity is supported by an educational grant from Ortho-McNeil™, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., administered by Ortho-McNeil Janssen Scientific Affairs, LLC.


Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.


Need help? Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or e-mail For technical assistance, please refer to our support manual.

View All CME/CE Programs

Follow Us